99 related articles for article (PubMed ID: 11438180)
1. Association of a CA repeat polymorphism upstream of the Fas ligand gene with multiple sclerosis.
Zayas MD; Lucas M; Solano F; Fernández-Pérez MJ; Izquierdo G
J Neuroimmunol; 2001 Jun; 116(2):238-41. PubMed ID: 11438180
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease.
Fogdell-Hahn A; Ligers A; Grønning M; Hillert J; Olerup O
Tissue Antigens; 2000 Feb; 55(2):140-8. PubMed ID: 10746785
[TBL] [Abstract][Full Text] [Related]
4. TAP2 polymorphisms in Australian multiple sclerosis patients.
Bennetts BH; Teutsch SM; Heard RN; Dunckley H; Stewart GJ
J Neuroimmunol; 1995 Jun; 59(1-2):113-21. PubMed ID: 7797612
[TBL] [Abstract][Full Text] [Related]
5. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
6. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.
Quelvennec E; Bera O; Cabre P; Alizadeh M; Smadja D; Jugde F; Edan G; Semana G
Tissue Antigens; 2003 Feb; 61(2):166-71. PubMed ID: 12694585
[TBL] [Abstract][Full Text] [Related]
7. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
8. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DR beta 1 chain in multiple sclerosis.
Ghabanbasani MZ; Gu XX; Spaepen M; Vandevyver C; Raus J; Marynen P; Carton H; Cassiman JJ
J Neuroimmunol; 1995 Jun; 59(1-2):77-82. PubMed ID: 7797622
[TBL] [Abstract][Full Text] [Related]
9. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
[TBL] [Abstract][Full Text] [Related]
10. HLA class II polymorphism in Latin American patients with multiple sclerosis.
Rojas OL; Rojas-Villarraga A; Cruz-Tapias P; Sánchez JL; Suárez-Escudero JC; Patarroyo MA; Anaya JM
Autoimmun Rev; 2010 Apr; 9(6):407-13. PubMed ID: 19896562
[TBL] [Abstract][Full Text] [Related]
11. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
[TBL] [Abstract][Full Text] [Related]
12. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the apo-1/Fas promoter mva I polymorphism in multiple sclerosis.
Huang QR; Teutsch SM; Buhler MM; Bennetts BH; Heard RN; Manolios N; Stewart GJ
Mult Scler; 2000 Feb; 6(1):14-8. PubMed ID: 10694840
[TBL] [Abstract][Full Text] [Related]
14. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
Fernández O; Fernández V; Alonso A; Caballero A; Luque G; Bravo M; León A; Mayorga C; Leyva L; de Ramón E
J Neurol; 2004 Apr; 251(4):440-4. PubMed ID: 15083289
[TBL] [Abstract][Full Text] [Related]
15. Human leucocyte antigen class II polymorphism in Irish patients with multiple sclerosis.
Dunne C; McGuigan C; Crowley J; Hagan R; Rooney G; Kelleher J; Hutchinson M; Lawlor E
Tissue Antigens; 2006 Sep; 68(3):257-62. PubMed ID: 16948649
[TBL] [Abstract][Full Text] [Related]
16. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus.
Gao XH; Barnardo MC; Winsey S; Ahmad T; Cook J; Agudelo JD; Zhai N; Powell JJ; Fuggle SV; Wojnarowska F
J Invest Dermatol; 2005 Nov; 125(5):895-9. PubMed ID: 16297186
[TBL] [Abstract][Full Text] [Related]
17. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis.
Castro F; Acevedo E; Ciusani E; Angulo JA; Wollheim FA; Sandberg-Wollheim M
Ann Rheum Dis; 2001 Aug; 60(8):791-5. PubMed ID: 11454644
[TBL] [Abstract][Full Text] [Related]
19. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami.
Harbo HF; Utsi E; Lorentzen AR; Kampman MT; Celius EG; Myhr KM; Lie BA; Mellgren SI; Thorsby E
Tissue Antigens; 2007 Apr; 69(4):299-304. PubMed ID: 17389012
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development.
Fiten P; Vandenbroeck K; Dubois B; Van Coillie E; Nelissen I; Van Damme J; Ligers A; Hillert J; Andersson M; Olsson T; Opdenakker G
J Neuroimmunol; 1999 Mar; 95(1-2):195-201. PubMed ID: 10229131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
